Skip to content
Life Sciences Series B Founded 2015

Trailhead Biosystems

Developer of cell therapies for the treatment of multiple diseases

📍 Beachwood, United States · Diversified Pharmaceuticals

Funding snapshot

Last roundSeries B
Amount$20M
Date12 January 2026

About

Developer of cell therapies for the treatment of multiple diseases. The company uses HD-DoE technology platform to develop a pipeline for diabetes, cancer, bone marrow, Huntington's disease, and more.

Latest news

No articles yet.

Raising like Trailhead Biosystems?

Analyze your pitch deck before your next raise.

Analyze My Deck →